These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19850592)

  • 1. Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.
    Rosencrantz MA; Wachs DS; Coffler MS; Malcom PJ; Donohue M; Chang RJ
    Hum Reprod; 2010 Jan; 25(1):198-203. PubMed ID: 19850592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome.
    Homer MV; Rosencrantz MA; Shayya RF; Chang RJ
    Reprod Biol Endocrinol; 2017 Feb; 15(1):13. PubMed ID: 28187771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2920-5. PubMed ID: 16720653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome.
    Coffler MS; Patel K; Dahan MH; Malcom PJ; Kawashima T; Deutsch R; Chang RJ
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1742-7. PubMed ID: 12679467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
    Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
    J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
    Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP; Laven JS; de Jong FH; Fauser BC
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.
    Maas KH; Chuan SS; Cook-Andersen H; Su HI; Duleba A; Chang RJ
    J Clin Endocrinol Metab; 2015 Jan; 100(1):293-300. PubMed ID: 25313914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.
    Buckler HM; McLachlan RI; MacLachlan VB; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Apr; 66(4):798-803. PubMed ID: 3126215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of functionally typical and atypical types of polycystic ovary syndrome.
    Hirshfeld-Cytron J; Barnes RB; Ehrmann DA; Caruso A; Mortensen MM; Rosenfield RL
    J Clin Endocrinol Metab; 2009 May; 94(5):1587-94. PubMed ID: 19240152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis.
    Welt CK; Taylor AE; Fox J; Messerlian GM; Adams JM; Schneyer AL
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5582-7. PubMed ID: 16030174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles.
    Elting MW; Kwee J; Korsen TJ; Rekers-Mombarg LT; Schoemaker J
    Fertil Steril; 2003 May; 79(5):1154-60. PubMed ID: 12738511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycystic ovarian syndrome.
    Caruso A; Fortini A; Fulghesu AM; Pistilli E; Cucinelli F; Lanzone A; Mancuso S
    Fertil Steril; 1993 Jan; 59(1):115-20. PubMed ID: 8419197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.